Latest / The Podcast by KevinMD

Inside the race to conquer the COVID-19 pandemic
"That year, 2020, Uğur told the crowd, would be the year BioNTech proved the doubters wrong.
There was no time to lose. Soon after he'd finished his talk, Uğur hopped on a plane to Seattle, where he met with a team at the Bill & Melinda Gates Foundation, which had recently signed a $100 million agreement with BioNTech to develop a slew of new drugs. Hours later, he moved on to Boston, to stop by a small cancer immunotherapy company that BioNTech was about to purchase in a $67 million deal. The purpose of the visit was to reassure staff that he, a fellow scientist, was interested in advancing…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.